Purpose: Smoking is a well-known risk factor for postoperative pulmonary complications. As a consequence of pre and postoperative procedures continuing to be developed, postoperative complications continue to decrease. In this study, smoking as a risk factor for postoperative pulmonary complications is studied. 
Introduction
Smoking is a well-reported risk factor for pulmonary complications, not only in major lung operations, 1, 2) but also in minor operations due to increased sputum release during the operation. 3) In particular, pulmonary resection through thoracotomy has long been linked with postoperative pulmonary complications. Importantly, these complications have signifi cantly infl uenced the relationship between morbidity and mortality of patient. 4) Surgical resection for lung cancer is the primary therapy for the disease, and consequently it is important to the treatment of early lung cancer. In spite of current improvements in the treatments of patients or surgical methods, including video-assisted thoracoscopic (VATS) lobectomy, pulmonary complications are still the primary cause for the development of these complications. 5) In this study, the authors tried to fi nd the relationship between smoking and postoperative pulmonary complications among patients who recently received pulmonary resection for the treatment of theirs.
Materials and Methods
From January 2005 to June 2009, from among lung cancer patients treated with surgical resection, a total of 232 patients with smoking experience were analyzed. Preoperative smoking status and postoperative pulmonary complications were analyzed retrospectively with medical chart reviews. According to preoperative smoking cessation duration, patients were categorized into three groups: group 1 included patients with less than 14 days of cessation (n = 74), group 2 included patients with 15 days to 1 month of cessation (n = 36), and fi nally group 3 included patients with more than one month of cessation (n = 122).
Postoperative pulmonary complications were defi ned as pneumonia, atelectasis, tracheostomy performed due to respiratory diffi culty, repeated intubation episodes after surgery, and persistent air leak of more than 7 days. Pneumonia was defi ned when a patient had a fever of more than 38°C of body temperature, pulmonary infi ltration on chest x-ray, and the indication of antibiotic therapy. Atelectasis was defi ned when a patient had lung collapse on chest x-ray, and received bronchoscopy due to pulmonary symptom, such as dyspnea.
The 
Results
The total number of patients was 232, with most being male (n = 217, 93.5%). In histological features, squamous cell carcinoma (n = 144) was more common than adenocarcinoma (n = 79). Lobectomy was the most common surgical procedure having been applied in 195 cases. VATS lobectomy accounted for 39 cases from among these lobectomy cases ( Table 1) .
In order to search the predictive indicators for pulmonary complications, patients were divided into two groups based on the existence or absence of pulmonary complications. A total of 48 patients with pulmonary complications were grouped together. In univariate analysis, body mass index (BMI) was a statistically signifi cant predictive indicator, but the average of the each group was still within the normal range, 22.5 and 23.6, respectively. Timing of smoking cessation and packyear index (PYI) also was not signifi cant ( Table 2) . Due to the small number of patients with pulmonary complications, a thorough comparison by complication type, such as pneumonia, atelectasis, tracheostomy, intubation, or persistent air leak, was unavailable in a group subdivided by timing of smoking cessation. Overall, persistent air leak was most common complication at 41 cases. However, complication development by smoking cessation duration was not signifi cant statistically ( Table 3) . Smoking factors and BMI that had been signifi cant in univariate analysis were analyzed by multivariate analysis, but the timing of cessation and PYI was not signifi cant, and BMI was the only signifi cant factor ( Table 4) .
Discussion
There have been a number of studies on risk factors for postoperative pulmonary complications, and, in particular, studies on smoking. 1, 3, 6, 7) Besides smoking, chronic obstructive pulmonary disease (COPD), emergency operation, major surgery requiring laparotomy, long surgery procedure time, or ventilation therapy upon completion of operation could also be other cause of postoperative pulmonary complications. 8, 9) Surgical resection is the primary therapy for the lung cancer patient. Postoperative morbidity of lung cancer slowly being reduced, but it remains at 0.5%. 10) The main cause of death is empyema and bronchopleural fi stula that occupied 40% in the past, but pneumonia and acute respiratory distress syndrome (ARDS), which occupy 46%, are the main cause of death in present. 10) Therefore, even though pulmonary complication types have been changed, the fact that pulmonary complications are indeed the most important cause of death following lung cancer surgery has not been changed. Not only do severe pulmonary complications, such as pneumonia or ARDS that could be the cause of death during hospitalization, but even mild complications can cause prolonged hospitalization or the increase of treatment cost. The most common postoperative pulmonary complications are persistent air leak and atelectasis, and, in particular, persistent air leak associated with prolonged hospitalization. 11) In this study, persistent air leak of more than 7 days was the most common pulmonary complication. Hospitalization time of a patient with complication is signifi cantly longer than a patient without complication. (22.17 days vs. 9.33 days, p value <0.0001).
The reason smoking history is the most critical from among the risk factors for postoperative complications is twofold: fi rst, because it is a predictive indicator that can be obtained prior to surgery, and secondly, cessation duration can be controlled prior to surgery. Lung cancer patients with a smoking history are at increased risk of postoperative complication. In addition, the less the duration of cessation, the greater risk the patient has of recurrence possibility and reduced survival rate. 12) For these reasons, a number of studies on pulmonary complications by smoking history have been reported. In general, smoking history is composed of whether a patient has ever smoked, the timing of smoking cessation, and PYI. Schwilk, et al. reported smoking as a signifi cant risk factor for postoperative pulmonary complication. 6) In a study of lung cancer patients, Mason, et al. reported inpatient mortality without smoking experience was 0.3%, but for patients with a smoking history, it was 1.5%. Furthermore, pulmonary complications occurred more frequently in patients in the smoking experience group, regardless of cessation duration. 13) Berrera, et al. also reported that if smoking experience exists, pulmonary complications, especially pneumonia, tend to occur more often. 14) Nevertheless, there is also a report that smoking experience is not signifi cantly related with pulmonary complications. 5) Many studies on timing of cessation and pulmonary complications have been done. 1, 5, [13] [14] [15] [16] [17] In the fi rst few days after smoking cessation, some patients complain of increased diffi culty clearing their tracheobronchial secretions, possibly due to an increase in the volume and viscosity of their sputum and a decrease in smoke-induced irritation of the tracheobronchial tree resulting in a decrease in coughing. Such diffi culty raises the concern that patients who quit smoking too close to operation might have an increased risk of pulmonary complications. 16) In a study on patients with multiple modes of surgical intervention, Bluman, et al. reported that pulmonary complications occurred more frequently if the duration of smoking cessation was less than 2 weeks. 1) In multivariate analysis, patients with smoking experience had pulmonary complications 4 times more often than did patients without smoking experience. However no signifi cant increase was observed if patients had stopped smoking for more than 2 weeks. 1) Moores, et al. insisted that a cessation of smoking six to eight weeks prior to surgery is optimal. 2) In a pneumonectomy study, Vaporciyan, et al. reported that patients who had preoperative smoking cessation duration times of less than one month showed pulmonary complications 2.7 times more often. 17) Mason, et al. presented the theory that the longer a patient stops smoking, the patient suffers less risk for postoperative pulmonary complications after lung cancer surgery. Unfortunately, they were unable to show the optimal cessation of smoking duration. 13) In contrast, recent studies have shown pulmonary complications after pulmonary resection and have not been signifi cantly related to the duration of smoking cessation. 5, 16) Groth, et al. suggested improvements in perioperative care such as risk reduction with perioperative beta-blockers, early ambulation, and improvements in respiratory therapy lead to a reduction in complication. 16) Shimizu, et al. explained some of the reasons for the reduced effect of smoking cessation; fi rstly, as CT technology continues to develop, more early lung cancers are identifi ed. Therefore VATS lobectomy techniques are being applied more commonly, and the number of pneumonectomies has decreased; secondly, improvement of preoperative patient management, anesthesia, and surgical methods; and thirdly, efforts to improve the patient's pulmonary function by using preoperative pulmonary function testing results. 5) In a study on PYI, Barrera, et al. demonstrated that smoking history of more than 60 pack-year is a signifi cant risk factor for developing pulmonary complications. 14) However, in another report based on 40 pack-years, signifi cant correlation with pulmonary complications was not revealed. 5) In an analysis of the present study, cessation duration and PYI were not signifi cant risk factors for postoperative pulmonary complication.
One limitation of this study includes the fact that non-smokers were excluded from the analysis. However, since most surgeons are interested if delay of the surgery is necessary to secure the optimal cessation duration in a patient who already has a smoking experience, it seems comparison with non-smoker is unnecessary. Secondly, the number of patients with pulmonary complications was small. In addition, detailed analysis of pulmonary complications was unavailable because most of the cases were persistent air leaks. Thirdly, BMI was a signifi cant risk factor in this study, but the BMI difference was only about 1 unit between complication group and noncomplication group (22.5 vs. 23.6). Furthermore, BMIs from the two groups were within the normal range; thus, they seem to have no important meaning clinically.
Conclusion
In the present study, smoking factors, such as smoking cessation duration and PYI, are not signifi cant risk factors for the development of pulmonary complications after lung cancer surgery. Accordingly, smoking cessation education is still recommended when treating lung cancer patients, but delay of surgery to secure a long smoking cessation duration seems unnecessary.
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